Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Current Deferred Revenue: 2009-2011

Historic Current Deferred Revenue for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $119,000.

  • Lexicon Pharmaceuticals' Current Deferred Revenue rose 156.71% to $421,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $421,000, marking a year-over-year increase of 156.71%. This contributed to the annual value of $119,000 for FY2011, which is 44.39% down from last year.
  • According to the latest figures from FY2011, Lexicon Pharmaceuticals' Current Deferred Revenue is $119,000, which was down 44.39% from $214,000 recorded in FY2010.
  • Lexicon Pharmaceuticals' Current Deferred Revenue's 5-year high stood at $942,000 during FY2009, with a 5-year trough of $119,000 in FY2011.
  • Its 3-year average for Current Deferred Revenue is $425,000, with a median of $214,000 in 2010.
  • Data for Lexicon Pharmaceuticals' Current Deferred Revenue shows a maximum YoY plummeted of 77.28% (in 2010) over the last 5 years.
  • Lexicon Pharmaceuticals' Current Deferred Revenue (Yearly) stood at $942,000 in 2009, then crashed by 77.28% to $214,000 in 2010, then crashed by 44.39% to $119,000 in 2011.